Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 65.94 |
| Open | 65.62 |
| Bid | 65.18 x 700 |
| Ask | 65.21 x 700 |
| Day's Range | 64.82 - 65.64 |
| 52 Week Range | 64.63 - 87.87 |
| Volume | |
| Avg. Volume | 7,430,732 |
| Market Cap | 81.302B |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | 181.11 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.08 (4.72%) |
| Ex-Dividend Date | Jun 14, 2024 |
| 1y Target Est | N/A |
- Insider Monkey
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
- Zacks
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- Simply Wall St.
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
© 2024 Yahoo. All rights reserved.